Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Proceedings of the National Academy of Sciences of the United States of America|October 20, 2010
Inhibition of the cation channel TRPV4 improves bladder function in mice and rats with cyclophosphamide-induced cystitisWouter Everaerts, Xiaoguang Zhen, Debapriya Ghosh, et al.
European Urology Oncology|August 15, 2019
Validation of the Decipher Test for Predicting Distant Metastatic Recurrence in Men with High-risk Nonmetastatic Prostate Cancer 10 Years After SurgeryThomas Van den Broeck, Lisa Moris, Thomas Gevaert, et al.
European Urology Oncology|December 30, 2025
Final Results of the Randomised Phase 2 Trial of Neoadjuvant Degarelix with or Without Apalutamide Prior to Radical Prostatectomy for High-risk Prostate Cancer (ARNEO)Alexander Giesen, Gaëtan Devos, Lorenzo Tosco, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Multi-omics integration and batch correction using a modality-agnostic deep learning frameworkJose Ignacio Alvira Larizgoitia, Gabriele Partel, Lorenzo Venturelli, et al.
Cancer Research|August 7, 2021
Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid CompositionLisa M Butler, Chui Yan Mah, Jelle Machiels, et al.
Advances in Anatomic Pathology|August 5, 2017
Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further ResearchShona Hendry, Roberto Salgado, Thomas Gevaert, et al.
Advances in Anatomic Pathology|August 5, 2017
Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain TumorsShona Hendry, Roberto Salgado, Thomas Gevaert, et al.
Pageof 7